SBK Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
SBK Financial's REGN Position: Q3 2026 in Review
SBK Financial sold out of Regeneron Pharmaceuticals (REGN) in Q3 2026, closing a stake of 12 shares — an estimated $7.48K sold.
SBK Financial first reported a position in REGN in Q2 2026 and held it in 1 quarter. The position peaked at $7.48K in Q2 2026. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- SBK Financial reported no remaining Regeneron Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- SBK Financial sold 12 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $7.48K.
- SBK Financial first reported a position in Regeneron Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- SBK Financial's Regeneron Pharmaceuticals position peaked at $7.48K in Q2 2026.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on SBK Financial's 13F filing for Q3 2026, filed 2 Nov 2026.